In the treatment of osteosarcoma, several flavonoids, including ugonin K, icaritin, genistein and KFL, promote osteoblast differentiation through their estrogenic effects, whereas galangin and hyperoside induce osteogenic differentiation by targeting TGF-β1. This evidence concerns the gene TGFB1 and osteosarcoma.